Cited by 3373D Printing in Biomedical ResearchCellular Mechanics and InteractionsMicrofluidic and Capillary Electrophoresis Applications

A three‐dimensional in vitro ovarian cancer coculture model using a high‐throughput cell patterning platform

Open access
Xu, Feng, Celli, Jonathan, Rizvi, Imran, Moon, Sangjun, Hasan, Tayyaba, Demirci, Utkan·2011·Biotechnology Journal

Abstract

In vitro 3D cancer models that provide a more accurate representation of disease in vivo are urgently needed to improve our understanding of cancer pathology and to develop better cancer therapies. However, development of 3D models that are based on manual ejection of cells from micropipettes suffer from inherent limitations such as poor control over cell density, limited repeatability, low throughput, and, in the case of coculture models, lack of reproducible control over spatial distance between cell types (e.g., cancer and stromal cells). In this study, we build on a recently introduced 3D model in which human ovarian cancer (OVCAR‐5) cells overlaid on Matrigel ™ spontaneously form multicellular acini. We introduce a high‐throughput automated cell printing system to bioprint a 3D coculture model using cancer cells and normal fi broblasts micropatterned on Matrigel ™ . Two cell types were patterned within a spatially controlled microenvironment (e.g., cell density, cell‐cell distance) in a high‐throughput and reproducible manner; both cell types remained viable during printing and continued to proliferate following patterning. This approach enables the miniaturization of an established macro‐scale 3D culture model and would allow systematic investigation into the multiple unknown regulatory feedback mechanisms between tumor and stromal cells and provide a tool for high‐throughput drug screening.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/biot.201000340

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Based on bioprinting technology, bioinks can create cell aggregates comprising different types of cells, including cancer-associated fibroblasts, immune cells and endothelial cells, to form vascular networks.

    “Based on bioprinting technology, bioinks can create cell aggregates comprising different types of cells, including cancer-associated fibroblasts, immune cells and endothelial cells, to form vascular networks153–155.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 37 · Cited by 337

Authors
Xu, F., Celli, J., Rizvi, I., Moon, S., Hasan, T., & Demirci, U.
Affiliations
  • Brigham and Women's Hospital (US)
  • Harvard University (US)
Corresponding author
Demirci, Utkan
Venue
Biotechnology Journal
Publisher
Wiley
Published
2011-02
Volume
6
Issue
2
Pages
204-212
ISSN
  • 1860-6768 (ISSN-L)
  • 1860-7314
OpenAlex
W1985133253
Cited by
337
References
37
Citations by year
2026: 7 · 2025: 16 · 2024: 17 · 2023: 24 · 2022: 31 · 2021: 34 · 2020: 27 · 2019: 23 · 2018: 35 · 2017: 30 · 2016: 28 · 2015: 20 · 2014: 14 · 2013: 11 · 2012: 10
FWCI
8.34
Type
journal article
Language
en
Open access
Locations
  • Biotechnology Journal (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Cancer Institute (P01CA084203, R01CA119388)
  • National Institute of Biomedical Imaging and Bioengineering (R21EB007707)
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
  • Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
Keywords
ovarian cancer, bioprinting, cell patterning, fibroblasts, Matrigel, tumor-stroma interactions, high-throughput drug screening, tumor microenvironment
MeSH terms
Cell Survival, Female, Humans, Microscopy, Ovarian Neoplasms, Cell Culture Techniques, Cell Line, Tumor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review